Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats

per Gupta, Deepali, Radhakrishnan, Mahesh, Bhatt, Shvetank, Kurhe, Yeshwant
Publicat 2013

Diabetes-associated depression: The serotonergic system as a novel multifunctional target

per Prabhakar, Visakh, Gupta, Deepali, Kanade, Prateek, Radhakrishnan, Mahesh
Publicat a Indian J Pharmacol (2015)

Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

per Gupta, Deepali, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Kurhe, Yeshwant
Publicat a J Pharm Bioallied Sci (2015)

Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice

per Kurhe, Yeshwant Vijay, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Gupta, Deepali
Publicat 2014

Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameter...

per Bhatt, Shvetank, Radhakrishnan, Mahesh, Jindal, Ankur, Devadoss, Thangaraj, Dhar, Arghya Kusum
Publicat 2014

Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression

per Gupta, Deepali, Radhakrishnan, Mahesh, Kurhe, Yeshwant, Thangaraj, Devadoss, Prabhakar, Visakh, Kanade, Prateek
Publicat a Acta Pharmacol Sin (2014)